Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials

Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD). New drug classes to augment renin–angiotensin–aldosterone system (RAAS) inhibitors as the standard of care have scarcely met their primary endpoints until recently. This sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia Sanchez, Juan Jose, Thompson, Juliette, Scott, David A., Evans, Rachel, Rao, Naveen, Sörstadius, Elisabeth, James, Glen, Nolan, Stephen, Wittbrodt, Eric T., Abdul Sultan, Alyshah, Stefansson, Bergur V., Jackson, Dan, Abrams, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799552/
https://www.ncbi.nlm.nih.gov/pubmed/34881414
http://dx.doi.org/10.1007/s12325-021-02006-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799552/
https://www.ncbi.nlm.nih.gov/pubmed/34881414
http://dx.doi.org/10.1007/s12325-021-02006-z

Ejemplares similares